Spectral properties of thioflavin T in solvents with different dielectric properties and in a fibril-incorporated form

Journal of Proteome Research

Volumn 6, Issue 4, 2007, Pages 1392-1401

  Maskevich, Alexander A ^a   Stsiapura, Vitali I ^a   Kuzmitsky, Valeriy A ^b   Kuznetsova, Irina M ^c   Povarova, Olga I ^c   Uversky, Vladimir N ^d,e   Turoverov, Konstantin K ^c  

^a YANKA KUPALA STATE UNIVERSITY OF GRODNO   (Belarus)

^b B I STEPANOV INSTITUTE OF PHYSICS   (Belarus)

^c INSTITUTE OF CYTOLOGY   (Russian Federation)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Absorption; Amyloid fibril; Fluorescence; Fluorescence excitation; Quantum chemical calculations; Solvent orientational polarizability; Solvent polarity; Thioflavin T

Indexed keywords

AMYLOID; ANILINE; THIOFLAVINE;

ABSORPTION SPECTROSCOPY; ARTICLE; CHEMICAL STRUCTURE; DIELECTRIC CONSTANT; FIBER; PRIORITY JOURNAL; SOLVATION;

AMYLOID; FLUORESCENCE; FLUORESCENT DYES; QUANTUM THEORY; SOLVENTS; SPECTROMETRY, FLUORESCENCE; THIAZOLES;

EID: 34248163484     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0605567     Document Type: Article

References (78)

1. Kelly, J. W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 1998, 8, 101-106.
2. Kelly, J. W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 1996, 6, 11-17.
3. Dobson, C. M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24, 329-332.
4. Bellotti, V.; Mangione, P.; Stoppini, M. Biological activity and pathological implications of misfolded proteins. Cell. Mol. Life Sci. 1999, 55, 977-991.
5. Uversky, V. N.; Talapatra, A.; Gillespie, J. R.; Fink, A. L. Protein deposits as the molecular basis of amyloidosis. Part I. Systemic amyloidoses. Med. Sci. Monitor 1999, 5, 1001-1012.
6. Uversky, V. N.; Talapatra, A.; Gillespie, J. R.; Fink, A. L. Protein deposits as the molecular basis of amyloidosis. II. Localized amyloidosis and neurodegenerative disorders. Med. Sci. Monitor 1999, 5, 1238-1254.
7. Rochet, J. C.; Lansbury, P. T., Jr. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 2000, 10, 60-68.
8. Uversky, V. N. Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go? Cell Mol. Life Sci. 2003, 60, 1852-1871.
9. Zerovnik, E. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur. J. Biochem. 2002, 269, 3362-3371.
10. Uversky, V. N.; Fink, A. L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta. 2004, 1698, 131-153.
11. Carrell, R. W.; Gooptu, B. Conformational changes and disease-serpins, prions and Alzheimer's. Curr. Opin. Struct. Biol. 1998, 8, 799-809.
12. Hashimoto, M.; Masliah, E. Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol. 1999, 9, 707-720.
13. Koo, E. H.; Lansbury, P. T., Jr.; Kelly, J. W. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9989-9990.
14. Chiti, F.; Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75, 333-366.
15. Gazit, E. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. Febs. J. 2005, 272, 5971-5978.
16. Sunde, M.; Blake, C. C. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 1998, 31, 1-39.
17. Sunde, M.; Serpell, L. C.; Bartlam, M.; Fraser, P. E.; Pepys, M. B.; Blake, C. C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 1997, 273, 729-739.
18. Goldsbury, C. S.; Cooper, G. J.; Goldie, K. N.; Muller, S. A.; Saafi, E. L.; Gruijters, W. T.; Misur, M. P.; Engel, A.; Aebi, U.; Kistler, J. Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 1997, 119, 17-27.
19. Harper, J. D.; Lieber, C. M.; Lansbury, P. T., Jr. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem. Biol. 1997, 4, 951-959.
20. Conway, K. A.; Harper, J. D.; Lansbury, P. T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 1998, 4, 1318-1320.
21. Serpell, L. C.; Sunde, M.; Benson, M. D.; Tennent, G. A.; Pepys, M. B.; Fraser, P. E. The protofilament substructure of amyloid fibrils. J. Mol. Biol. 2000, 300, 1033-1039.
22. Uversky, V. N.; Li, J.; Fink, A. L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 2001, 276, 10737-10744.
23. Nielsen, L.; Frokjaer, S.; Brange, J.; Uversky, V. N.; Fink, A. L. Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 2001, 40, 8397-8409.
24. Souillac, P. O.; Uversky, V. N.; Millett, I. S.; Khurana, R.; Doniach, S.; Fink, A. L. Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH. J. Biol. Chem. 2002, 277, 12666-12679.
25. Souillac, P. O.; Uversky, V. N.; Millett, I. S.; Khurana, R.; Doniach, S.; Fink, A. L. Effect of association state and conformational stability on the kinetics of immunoglobulin light chain amyloid fibril formation at physiological pH. J. Biol. Chem. 2002, 277, 12657-12665.
26. Guijarro, J. I.; Sunde, M.; Jones, J. A.; Campbell, I. D.; Dobson, C. M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4224-4228.
27. Litvinovich, S. V.; Brew, S. A.; Aota, S.; Akiyama, S. K.; Haudenschild, C.; Ingham, K. C. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol. 1998, 280, 245-258.
28. Konno, T.; Murata, K.; Nagayama, K. Amyloid-like aggregates of a plant protein: a case of a sweet-tasting protein, monellin. FEBS Lett 1999, 454, 122-126.
29. Schuler, B.; Rachel, R.; Seckler, R. Formation of fibrous aggregates from a non-native intermediate: the isolated P22 tailspike beta-helix domain. J. Biol. Chem. 1999, 274, 18589-18596.
30. Gross, M.; Wilkins, D. K.; Pitkeathly, M. C.; Chung, E. W.; Higham, C.; Clark, A.; Dobson, C. M. Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci. 1999, 8, 1350-1357.
31. Chiti, F.; Webster, P.; Taddei, N.; Clark, A.; Stefani, M.; Ramponi, G.; Dobson, C. M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3590-3594.
32. Krebs, M. R.; Wilkins, D. K.; Chung, E. W.; Pitkeathly, M. C.; Chamberlain, A. K.; Zurdo, J.; Robinson, C. V.; Dobson, C. M. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J. Mol. Biol. 2000, 300, 541-549.
33. Damaschun, G.; Damaschun, H.; Fabian, H.; Gast, K.; Krober, R.; Wieske, M.; Zirwer, D. Conversion of yeast phosphoglycerate kinase into amyloid-like structure. Proteins 2000, 39, 204-211.
34. Yutani, K.; Takayama, G.; Goda, S.; Yamagata, Y.; Maki, S.; Namba, K.; Tsunasawa, S.; Ogasahara, K. The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile, Pyrococcus furiosus. Biochemistry 2000, 39, 2769-2777.
35. Ohnishi, S.; Koide, A.; Koide, S. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet. J. Mol. Biol. 2000, 301, 477-489.
36. Fezoui, Y.; Hartley, D. M.; Walsh, D. M.; Selkoe, D. J.; Osterhout, J. J.; Teplow, D. B. A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat. Struct. Biol. 2000, 7, 1095-1099.
37. Fandrich, M.; Fletcher, M. A.; Dobson, C. M. Amyloid fibrils from muscle myoglobin. Nature 2001, 410, 165-166.
38. Pertinhez, T. A.; Bouchard, M.; Tomlinson, E. J.; Wain, R.; Ferguson, S. J.; Dobson, C. M.; Smith, L. J. Amyloid fibril formation by a helical cytochrome. FEBS Lett 2001, 495, 184-186.
39. Goers, J.; Permyakov, S. E.; Permyakov, E. A.; Uversky, V. N.; Fink, A. L. Conformational prerequisites for alpha-lactalbumin fibrillation. Biochemistry 2002, 41, 12546-12551.
40. Pavlov, N. A.; Cherny, D. I.; Heim, G.; Jovin, T. M.; Subramaniam, V. Amyloid fibrils from the mammalian protein prothymosin alpha. FEBS Lett 2002, 517, 37-40.
41. Munishkina, L. A.; Fink, A. L.; Uversky, V. N. Conformational prerequisites for formation of amyloid fibrils from histones. J. Mol. Biol. 2004, 342, 1305-1324.
42. Xu, M.; Ermolenkov, V. V.; He, W.; Uversky, V. N.; Fredriksen, L.; Lednev, I. K. Lysozyme fibrillation: deep UV Raman spectroscopic characterization of protein structural transformation. Biopolymers 2005, 79, 58-61.
43. Morozova-Roche, L. A.; Zamotin, V.; Malisauskas, M.; Ohman, A.; Chertkova, R.; Lavrikova, M. A.; Kostanyan, I. A.; Dolgikh, D. A.; Kirpichnikov, M. P. Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways. Biochemistry 2004, 43, 9610-9619.
44. Sambashivan, S.; Liu, Y.; Sawaya, M. R.; Gingery, M.; Eisenberg, D. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 2005, 437, 266-269.
45. Sipe, J. D.; Cohen, A. S. Review: history of the amyloid fibril. J. Struct. Biol. 2000, 130, 88-98.
46. Nelson, R.; Eisenberg, D. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 2006, 16, 260-265.
47. Wickner, R. B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994, 264, 566-569.
48. Patino, M. M.; Liu, J. J.; Glover, J. R.; Lindquist, S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996, 273, 622-626.
49. Serio, T. R.; Cashikar, A. G.; Kowal, A. S.; Sawicki, G. J.; Moslehi, J. J.; Serpell, L.; Arnsdorf, M. F.; Lindquist, S. L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000, 289, 1317-1321.
50. Serio, T. R.; Lindquist, S. L. Protein-only inheritance in yeast: something to get (PSI+]-ched about. Trends Cell Biol. 2000, 10, 98-105.
51. King, C. Y.; Diaz-Avalos, R. Protein-only transmission of three yeast prion strains. Nature 2004, 428, 319-323.
52. Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. O.; Riekel, C.; Grothe, R.; Eisenberg, D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005, 435, 773-778.
53. Naiki, H.; Higuchi, K.; Hosokawa, M.; Takeda, T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem. 1989, 177, 244-249.
54. Naiki, H.; Higuchi, K.; Matsushima, K.; Shimada, A.; Chen, W. H.; Hosokawa, M.; Takeda, T. Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T. Lab. Invest. 1990, 62, 768-773.
55. LeVine, H., 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993, 2, 404-410.
56. LeVine, H., 3rd. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils. Arch. Biochem. Biophys. 1997, 342, 306-316.
57. LeVine, H., 3rd. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309, 274-284.
58. Yoshiike, Y.; Chui, D. H.; Akagi, T.; Tanaka, N.; Takashima, A. Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation. J. Biol. Chem. 2003, 278, 23648-23655.
59. Allsop, D.; Swanson, L.; Moore, S.; Davies, Y.; York, A.; El-Agnaf, O. M.; Soutar, I. Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregation. Biochem. Biophys. Res. Commun. 2001, 285, 58-63.
60. LeVine, H., 3rd. Thioflavine T interaction with amyloid -sheet structures. Amyloid. Int. J. Exp. Clin. Invest. 1995, 2, 1-6.
61. Hobbs, J. R.; Morgan, A. D. Fluorescence Microscopy with Thioflavine-T in the Diagnosis of Amyloid. J. Pathol. Bacteriol. 1963, 86, 437-442.
62. Kumita, J. R.; Weston, C. J.; Choo-Smith, L. P.; Woolley, G. A.; Smart, O. S. Prevention of peptide fibril formation in an aqueous environment by mutation of a single residue to Aib. Biochemistry 2003, 42, 4492-4498.
63. Zhu, L.; Zhang, X. J.; Wang, L. Y.; Zhou, J. M.; Perrett, S. Relationship between stability of folding intermediates and amyloid formation for the yeast prion Ure2p: a quantitative analysis of the effects of pH and buffer system. J. Mol. Biol. 2003, 328, 235-254.
64. Ban, T.; Hamada, D.; Hasegawa, K.; Naiki, H.; Goto, Y. Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J. Biol. Chem. 2003, 278, 16462-16465.
65. Turoverov, K. K.; Biktashev, A. G.; Dorofeiuk, A. V.; Kuznetsova, I. M. A. complex of apparatus and programs for the measurement of spectral, polarization and kinetic characteristics of fluorescence in solution. Tsitologiia 1998, 40, 806-817.
66. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
67. Stewart, J. J. P. Optimization of parameters for semiempirical methods II. Applications. J. Comput. Chem. 1989, 10, 221-264.
68. Binkley, J. S.; Pople, J. A.; Hehre, W. J. Self-consistent molecular orbital methods. 21. Small split-valence basis sets for first-row elements. J. Am. Chem. Soc. 1980, 102, 939-947.
69. Hehre, W. J.; Ditchfield, R.; Pople, J. A. Self-Consistent Molecular Orbital Methods. XII. Further Extensions of Gaussian-Type Basis Sets for Use in Molecular Orbital Studies of Organic Molecules. J. Chem. Phys. 1972, 56, 2257-2261.
70. Hariharan, P. C.; Pople, J. A. The influence of polarization functions on molecular orbital hydrogenation energies. Theoret. Chim. Acta. 1973, 28, 213-222.
71. Zerner, M. C.; Loew, G. H.; Kirchner, R. F.; Mueller-Westerhoff, U. T. An intermediate neglect of differential overlap technique for spectroscopy of transition-metal complexes. Ferrocene. J. Am. Chem. Soc. 1980, 102, 589-599.
72. Nemukhin, A. V.; Grigorenko, B. L.; Granovsky, A. A. Molecular modeling by using the PC GAMESS program: From diatomic molecules to enzymes. Moscow Univ. Chem. Bull. 2004, 45, 75.
73. Schmidt, M. W.; Baldridge, K. K.; Boatz, J. A.; Elbert, S. T.; Gordon, M. S.; Jensen, J. J.; Koseki, S.; Matsunaga, N.; Nguyen, K. A.; Su, S.; Windus, T. L.; Dupuis, M.; Montgomery, J. A. General atomic and molecular electronic structure system. J. Comput. Chem. 1993, 14, 1347-1363.
74. Portmann, S.; Luthi, H. P. MOLEKEL: An Interactive Molecular Graphics Tool. CHIMIA 2000, 54, 766-770.
75. Lakowicz, J. R. Principles of Fluorescence Spectroscopy, 2nd ed.; Kluwer Academic/Plenum Publishers: New York, 1999.
76. Voropay, E. S.; Samtsov, M. P.; Kaplevsky, K. N.; Maskevich, A. A.; Stepuro, V. I.; Povarova, O. I.; Kuznetsova, I. M.; Tutoverov, K. K.; Fink, A. L.; Uversky, V. N. Spectral properties of Thioflavine T and its complexes with amyloid fibrils. J. Appl. Spectrosc. 2003, 70, 868-874.
77. Muller, M. G.; Hardy, E. H.; Vogt, P. S.; Bratschi, C.; Kirchner, B.; Huber, H.; Searles, D. J. Calculation of the deuteron quadrupole relaxation rate in a mixture of water and dimethyl sulfoxide. J. Am. Chem. Soc. 2004, 126, 4704-4710.
78. Omta, A. W.; Kropman, M. F.; Woutersen, S.; Bakker, H. J. Negligible effect of ions on the hydrogen-bond structure in liquid water. Science 2003, 301, 347-349.